Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)-KSNS

ÇмúÇà»ç

·Î±×ÀÎ ¾ÆÀ̵ð ±â¾ï
 
ÇмúÇà»ç¸ñ·Ï Home > ÇмúÇà»ç > ÇмúÇà»ç¸ñ·Ï
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2018³â Á¦34Â÷ Workshop °³ÃÖ ¾È³»
ÀÛ¼ºÀÚ °ü¸®ÀÚ email http://www.nonclinical.or.kr
Date2018³â 09¿ù 12ÀÏ 20:09Hits7858
÷ºÎÆÄÀÏ Files(559 kb) [°ø¹®] KSNS 34Â÷ ¿öÅ©¼¥ °³ÃÖ ¾È³»
Files(1740 kb) Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2018³â Á¦34Â÷ Workshop ¸®Ç÷¿

Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2018³â Á¦34Â÷ Workshop °³ÃÖ
"Boost pharma R&D productivity through open innovation"
2018³â 10¿ù 25ÀÏ(¸ñ) ~ 26ÀÏ(±Ý) / °ïÁö¾Ï ¸®Á¶Æ® Grand Ballroom



1. ±Í»çÀÇ ¹«±ÃÇÑ ¹ßÀü°ú ±ÍÇÏÀÇ °Ç½ÂÇϽÉÀ» ±â¿øÇÕ´Ï´Ù.
2. Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸¿¡¼­´Â Á¦34Â÷ ¿öÅ©¼¥À» ¡°Boost pharma R&D productivity through open innovation" À̶ó´Â ÁÖÁ¦·Î ´ÙÀ½°ú °°ÀÌ °³ÃÖÇÏ¿À´Ï, ȸ¿ø ¿©·¯ºÐÀÇ ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.


¡á Çà»ç°³¿ä

Çà»ç¸í Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2018³â Á¦34Â÷ Workshop
ÁÖÁ¦ Boost pharma R&D productivity through open innovation
ÀϽà 2018³â 10¿ù 25ÀÏ(¸ñ) 12:00 ~ 26ÀÏ(±Ý) 15:00
Àå¼Ò °ïÁö¾Ï¸®Á¶Æ® Grand Ballroom (EWºô¸®Áö B2) ÀÚ¼¼È÷ º¸±â
ÁÖ¼Ò : °æ±âµµ ±¤Áֽà µµÃ´¸é µµÃ´À­·Î 278
»çÀüµî·Ï 2018³â 9¿ù 17ÀÏ (¿ù) ~ 10¿ù 12ÀÏ (±Ý)
»çÀüµî·Ï±â°£ 2018³â 9¿ù 17ÀÏ (¿ù) ~ 10¿ù 12ÀÏ (±Ý)
1) ȨÆäÀÌÁö (www.nonclinical.or.kr)³» Á¦34Â÷ ¿öÅ©¼¥ »çÀüµî·Ï ¸Þ´º ÀÌ¿ë
2) ºñȸ¿øÀº ȸ¿ø°¡ÀÔ ÈÄ µî·Ï °¡´É
µî·Ïºñ »çÀüµî·Ï 10¸¸¿ø(Çлý 6¸¸¿ø), ÇöÀåµî·Ï 15¸¸¿ø(Çлý 10¸¸¿ø)
1) »çÀüµî·Ï Ä«µå°áÁ¦ °¡´É.(Ä«µå°áÁ¦ ½Ã ¼¼±Ý°è»ê¼­ ¹ßÇàºÒ°¡)
2) ÀÚ·áÁý, ¼ö·áÁõ, ¼÷¹Ú (4~5ÀÎ/1½Ç), 25ÀÏ Áᫎ ¹× ¼®½Ä, 26ÀÏ Á¶½Ä ¹× Áᫎ Æ÷ÇÔ
3) ¼¼±Ý°è»ê¼­ ¹ß±Þ (ÀÔ±ÝÀÏ ±âÁØ 1ȸ ¹ß±Þ)ÀÌ ÇÊ¿äÇϽŠºÐÀº »ç¾÷ÀÚµî·ÏÁõ ÷ºÎ ¿ä¸Á
4) ÇöÀåµî·ÏÀÇ °æ¿ì, ¼¼±Ý°è»ê¼­ ¹ß±Þ ºÒ°¡, ¿¬±¸È¸ ÀÚü ¿µ¼öÁõ ¹ß±Þ
5) ÀԱݰèÁ : ¿ì¸®ÀºÇà 1005-403-436526 ¢ßµå¸²ÆÄÆ®³Ê Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸
6) ÀԱݸ¶°¨ : 2018³â 10¿ù 12ÀÏ(±Ý), ÀÔ±Ý ½Ã ¼Ò¼Ó, ¼º¸í ±âÀÔ ¿ä¸Á
¹®ÀÇ ±âŸ ¹®ÀÇ»çÇ×Àº Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
KSNS »ç¹«±¹ : Tel. 031-702-9123 / E-mail. ksns@nonclinical.or.kr / ´ã´çÀÚ. ±èÁذï
º°Ã· [°ø¹®] KSNS 34Â÷ ¿öÅ©¼¥ °³ÃÖ ¾È³» [¾È³»] KSNS 34Â÷ ¿öÅ©¼¥ ¸®Ç÷¿


¡á µî·Ï¾È³»

- »çÀüµî·Ï ¾È³»

µî·Ï±â°£ 2018³â 9¿ù 17ÀÏ (¿ù) ~ 10¿ù 12ÀÏ (±Ý)
µî·Ï¹æ¹ý - ¿¬±¸È¸ ȨÆäÀÌÁö (www.nonclinical.or.kr) ÇмúÇà»ç >»çÀüµî·Ï ¸Þ´º ÀÌ¿ë
- ºñȸ¿øÀº ȸ¿ø°¡ÀÔ ÈÄ, »çÀüµî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.

- µî·Ïºñ <Áß¿ä°øÁö >Ä«µå°áÁ¦ °¡´É

µî·Ïºñ ±¸ºÐ »çÀüµî·Ï ÇöÀåµî·Ï
Á¤È¸¿ø 100,000¿ø 150,000¿ø
Çлýȸ¿ø 60,000¿ø 100,000¿ø
• »çÀüµî·Ïºñ : ÀÚ·áÁý, ¼ö·áÁõ, ¼÷¹Ú (4~5ÀÎ/1½Ç), 25ÀÏ Áᫎ ¹× ¼®½Ä, 26ÀÏ Á¶½Ä ¹× Áᫎ Æ÷ÇÔ
¼¼±Ý°è»ê¼­ ¹ß±Þ(ÀÔ±ÝÀÏ ±âÁØ 1ȸ ¹ß±Þ)ÀÌ ÇÊ¿äÇÒ °æ¿ì, ¿Â¶óÀÎ µî·Ï¶§ ¼¼±Ý°è»ê¼­ ¹ßÇàÇà¿©ºÎ¸¦ üũÇϰí, »ç¾÷ÀÚµî·ÏÁõ »çº»À» ¹Ýµå½Ã ÷ºÎ
ÇöÀåµî·Ï ¹× Çлýµî·ÏÀÇ °æ¿ì, ¼¼±Ý°è»ê¼­ ¹ß±Þ ºÒ°¡, ¿¬±¸È¸ ÀÚü ¿µ¼öÁõ ¹ß±Þ

- ¹«ÅëÀåÀÔ±Ý (°èÁÂÀÌü)

ÀԱݰèÁ ¿ì¸®ÀºÇà 1005-403-436526 ¢ßµå¸²ÆÄÆ®³Ê Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸
ÀԱݰèÁ ~ 2018³â 10¿ù 12ÀÏ (±Ý) 18½Ã ±îÁö
ÀԱݽà ¹Ýµå½Ã "¼Ò¼Ó/¼º¸í" À» ±âÀÔÇϼ¼¿ä.
• ¹«ÅëÀå ÀÔ±Ý(°èÁÂÀÌü)ÀÌü ÈÄ, »ç¹«±¹¿¡¼­ ÀÔ±ÝÀ» È®ÀÎÇÏ´Â ½Ã°£ÀÌ ÇÊ¿ä ÇÕ´Ï´Ù.
• ±âŸ µî·Ï °ü·Ã ¹®ÀÇ»çÇ×Àº Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
  TEL. 031-702-9123 / E-mail. ksns@nonclinical.or.kr, ±èÁذï


¡á ÇÁ·Î±×·¥ ¾È³»

  • ÀϽà : 2018³â 10¿ù 25ÀÏ(¸ñ) 12:00 ~ 26ÀÏ(±Ý) 15:00
  • Àå¼Ò : °ïÁö¾Ï¸®Á¶Æ® Grand Ballroom (EWºô¸®Áö B2)
  • ÁÖÁ¦ : Boost pharma R&D productivity through open innovation

Day 1 10¿ù 25ÀÏ (¸ñ)
½Ã°£ ÇÁ·Î±×·¥
12:00~13:00 µî·Ï ¹× Á¡½Ä ½Ä»ç
13:00~13:10 °³È¸»ç (¿À¼¼¿õ ȸÀå)
Session 1 Plenary talk
13:10~13:50 Success factors in drug discovery and development (º¸·ÉÁ¦¾à, ±è´ÞÇö)
13:50~14:30 ½Å¾à°³¹ß¿¡ À־ º¥Ã³Ä³ÇÇÅ»ÀÇ ¿ªÇÒ (¿¡ÀÌÆ¼³Ñ, °û»óÈÆ)
Session 2 Platform
14:30~15:10 Discovering New Drug Target through Systemic KO Mouse Phenotyping (¼­¿ï´ë, ¼ºÁ¦°æ)
15:10~15:50 Protac-induced protein degradation for the next small molecule drug discovery
(Çѱ¹È­Çבּ¸¿ø, ȲÁ¾¿¬)
15:50~16:20 Booth exhibition & Coffee break
Session 3 Case study 1
16:20~17:00 Nonclinical Studies for Human Clinical Trials of Gene Therapy : case studies of VM202 and VM206 (¹ÙÀÌ¿À¸Þµå, Á¤Àç±Õ)
17:00~17:40 JW1601, an orally available histamine H4 receptor inverse agonist, with anti-pruritic & anti-inflammatory dual effect as a treatment for atopic dermatitis (JWÁß¿ÜÁ¦¾à, È£Çʼö)
18:30~21:00 ÃÑȸ & Social networking

Day 2 10¿ù 26ÀÏ (±Ý)
½Ã°£ ÇÁ·Î±×·¥
07:00~09:00 ¾ÆÄ§ ½Ä»ç
Session 4 ¾àÈ¿ºÐ°ú µ¶¼ººÐ°ú ¾àµ¿ºÐ°ú
09:00~09:40 Supporting Chemistry with Big Data : CognitiveIT technologies
(OntoChem, Dr.Michael Ahrweiler)
»ê¾÷È­Çй°ÁúÀÇ ÈíÀÔµ¶¼º¿¬±¸(»ê¾÷¾ÈÀüº¸°Ç¿¬±¸¿ø, ±è¿ë¼ø) Strategies to determine the target human metabolites using radiolabeled compounds - Example from non-clinical to clinical (Axcelead, Fumihiro Jinno)
09:40~10:20 BIONEER'S Novel RNAi Drug Platform SAMiRNA¢â
(¹ÙÀÌ¿À´Ï¾î, À±Æò¿À)
SEND¿Í ºñÀÓ»ó½ÃÇèÀÚ·áÀÇ Ç¥ÁØÈ­
(¾ÈÀü¼ºÆò°¡¿¬±¸¼Ò, ÀÓ¿ÏÁß)
Preclinical PK of 2 NCEs for IND Submission
(Ãæ³²´ë, ±¸Å¼º)
10:20~10:40 Booth exhibition & Coffee break
10:40~11:20 Age-related Clonal Hematopoiesis: A Novel Target for Disease Treatment
(Áö³ð ¿ÀÇǴϾð, ÀÓÈ£±Õ)
ºñÀÓ»ó ½ÃÇè °ü¸® ±ÔÁ¤ º¯°æ¿¡ µû¸¥ ÇØ¼³¼­ °³Á¤¿¬±¸
(°Ç¾ç´ë, ȲÁø¾Æ)
2018 FDA MV Guidance: Key Changes and Considerations
(³ì½ÊÀÚÀÇ·áÀç´Ü, ÀÌÈñÁÖ)
11:20~12:00 Anti-diabetic effects of novel PTP1B inhibitors isolated from Stereocaulon alpinum
(¼º±Õ°ü´ë, Á¶µ¿±Ô)
´ëüµ¶¼º½ÃÇè°ú GLP À̽´
(ÄÍ¿Â, ¿ÀÁ¤ÀÚ)
Major Changes in Current FDA Guideline for In-vitro Drug-Drug Interaction Studies
(À¯ÇѾçÇà, ±èµ¿±Õ)
12:00~13:30 Luncheon seminar & Booth exhibition
Session 5 Case study 2
13:30~14:10 Challenges and Strategies of Biosimilar Clinical Development (»ï¼º¹ÙÀÌ¿À·ÎÁ÷½º, Á¤Áø¾Æ)
14:10~14:50 Open Innovation: Strategy & Cases (À¯ÇѾçÇà, ¿À¼¼¿õ)
14:50~15:00 Æóȸ»ç ¹× °æÇ° Ãß÷ (ºÎȸÀå, ½ÉÇöÁÖ)
* »ó±â ÇÁ·Î±×·¥Àº ¿¬ÀÚ ¹× ±âŸ »çÁ¤À¸·Î º¯µ¿ ¼ö ÀÖ½À´Ï´Ù.

¡á ¿À½Ã´Â ±æ

ÁÖ¼Ò °æ±âµµ ±¤Áֽà µµÃ´¸é µµÃ´À­·Î 278, EWºô¸®Áö B2
ȨÆäÀÌÁö °ïÁö¾Ï ¸®Á¶Æ® (°æ±âµµ ±¤ÁÖ) ÀÚ¼¼È÷ º¸±â
ÁÖÂ÷ ¸®Á¶Æ® ³» EWºô¸®Áö/Lºô¸®Áö ÁöÇÏ ÁÖÂ÷Àå, 5~7¹ø ÁÖÂ÷ÀåÀº Åõ¼÷°´(»çÀü¿¹¾àÁ¦)À» À§ÇÑ
ÁÖÂ÷ÀåÀÔ´Ï´Ù.
´ëÁß±³Åë [ ÁöÇÏö/Àüö ÀÌ¿ë½Ã ]
- °ïÁö¾Ï Àüö¿ª ÇÏÂ÷ ÈÄ Åýà ¹× ¼øÈ¯¹ö½º ÀÌ¿ë
- °ïÁö¾Ï Àüö¿ª ¼øÈ¯¹ö½º ¿îÇà
¡Ø ¼øÈ¯¹ö½º(45ÀνÂ/1½Ã°£ °£°Ý ¿îÇà/ÀÔ¼® Á¦ÇÑ) > Åýà ÀÌ¿ë ±ÇÀå

[ ±¤¿ª¹ö½º ÀÌ¿ë ½Ã ] (1113-1, 500-1, 500-2)
- °ïÁö¾Ï Å͹̳ΠÇÏÂ÷ ÈÄ Åýà ¹× ¼øÈ¯¹ö½º ÀÌ¿ë
- °ïÁö¾Ï Å͹̳Π¼øÈ¯¹ö½º ¿îÇà
¡Ø ¼øÈ¯¹ö½º(45ÀνÂ/1½Ã°£ °£°Ý ¿îÇà/ÀÔ¼® Á¦ÇÑ) > Åýà ÀÌ¿ë ±ÇÀå
¼øÈ¯¹ö½º °ïÁö¾Ï ¡ç¡æ ¸®Á¶Æ® ¿îÇà ¼øÈ¯¹ö½º (45ÀνÂ/ÀÔ¼® Á¦ÇÑ)
- °ïÁö¾ÏÅ͹̳Πž½ÂÀå¼Ò : °ïÁö¾ÏÅ͹̳Π¸ÂÀºÆí ´Ù¼Ö¾à±¹ ¾Õ
- °ïÁö¾Ï¸®Á¶Æ® ž½ÂÀå¼Ò : 4¹ø ÁÖÂ÷Ÿ¿ö µÞÆí
- °ïÁö¾Ï Àüö¿ª ž½ÂÀå¼Ò : °ïÁö¾ÏÀüö¿ª Kiss&Ride ž½ÂÀå



KSNS 34Â÷ ¿öÅ©¼¥ ¸®Ç÷¿




List
°³ÀÎÁ¤º¸Ãë±Þ¹æÄ§
(ÁÖ)µå¸²ÆÄÆ®³Ê (»ç¾÷ÀÚµî·Ï¹øÈ£ : 320-88-00843, ´ëÇ¥ : ±è»ó¿ì)
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)
(¿ì)446-982 °æ±âµµ ¿ëÀνà ±âÈﱸ Èï´öÁß¾Ó·Î 120 U-TOWER 1411È£
Tel : 031-702-9123 , Fax : 031-213-9125, E-Mail : ksns@nonclinical.or.kr
Copyright & "The Korean Society Nonclinical Study". Website development and maintenance: "Expedition". All Rights Reserved.